Table 1.

Characteristics of the participants at baseline

Baseline CharacteristicsAll Subjects (n=66)
Age, yr56±12
Male, n (%)46 (70)
Race, n (%)
 Asian23 (35)
 Black35 (53)
 White7 (11)
 Other1 (1)
ESKD vintage, yr2.4 (1.2, 5.3)
Vascular access, n (%)
 AV fistula46 (71)
 AV graft16 (25)
 Catheter3 (5)
Comorbid conditions, n (%)
 Diabetes mellitus28 (43)
 Hyperlipidemia40 (61)
 Hypertension56 (85)
 Ischemic heart disease32 (48)
 Congestive heart failure17 (26)
 Arrhythmia21 (32)
 Atrial fibrillation7 (11)
Systolic BP, mm Hg141±23
Diastolic BP, mm Hg77±13
Medication use, n (%)
 Aspirin30 (45)
 Statin32 (48)
 ACEI or ARB22 (33)
 Beta blockers36 (55)
Predialysis serum laboratory values
 BUN, mg/dl60±18
 Creatinine, mg/dl10.0±3.4
 Sodium, mEq/L137±4
 Potassium, mEq/L5.0±1.0
 Calcium, mg/dl8.7±0.8
 Bicarbonate, mEq/L22±4
 Magnesium, mg/dl2.4±0.5
 Phosphate, mg/dl5.5±2.0
 Hemoglobin, g/dl11±1
 Serum albumin, g/dl3.9±0.3
  • Continuous variables are presented as mean±SD or median (25th, 75th percentiles). AV, arteriovenous; ACEI, angiotensin converting enzyme inhibitor; ARB, angiotensin receptor blocker.